Recently added articles from AIDS Vaccine Week:
Research findings from H.B. Yang et al update understanding of highly active antiretroviral therapy.
Dec 21, 2009 ... According to a study from Oxford, the United Kingdom, "We investigated whether therapeutic vaccination in highly active antiretroviral therapy (HAART)treated patients with a modified vaccinia virus Ankara-vectored HIV-1 vaccine, with or without therapy interruption, induced the production ...
New HIV/AIDS vaccine findings from T.W. Valente and co-authors described.(Clinical report)
Dec 21, 2009 ... In this recent study, researchers in the United States conducted a study "To evaluate a social network approach to develop an adolescent cohort for HIV vaccine preparedness and investigate characteristics that influence recruitment. We summarize baseline data from a prospective cohort ...
Reports on simian immunodeficiency virus findings from P. Vagenas and co-researchers provide new insights.
Dec 21, 2009 ... "Although mucosal responses are important for preventing infections with HIV, the optimal strategies for inducing them remain unclear. To evaluate vaccine strategies targeting the oral mucosal lymphoid tissue inductive sites as an approach to provide immunity at distal sites, we vaccinated ...
Reports summarize tuberculosis study results from I. Verma and co-researchers.
Dec 21, 2009 ... According to a study from Chandigarh, India, "Several new antituberculous vaccine candidates that are effective against primary infection in preclinical animal models have now entered the early phases of clinical trials." "Many of these clinical trials involve subunit vaccines, ...
Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline.(Report)
Dec 21, 2009 ... BioWorld Today recently highlighted a new report published by the Pharmaceutical Research and Manufacturers of America (PhRMA) that identifies 97 new drugs and vaccines in development to treat or prevent HIV/AIDS and related conditions (see also Pharmaceutical Research and Manufacturers of ...